Fig. 3From: Real-world effectiveness and satisfaction with intravenous eptinezumab treatment in patients with chronic migraine: REVIEW, an observational, multi-site, US-based studyPatient-reported satisfaction with eptinezumab’s ability to impact migraine symptomsPercentages may not add up to 100% due to rounding. Patients were prompted: “Please rate how much you agree or disagree with the following statements by placing a checkmark ✓ in the column which most closely fits your opinion: I am satisfied with eptinezumab’s ability to…” Choices included: strongly agree, agree, neutral, disagree, and strongly disagree.Back to article page